Gram-negative (1)
Rod-shaped, coccoid, or ovoid bacterium (2)
Causes whooping cough
Highly contagious infection
Found in mouth, nose, and respiratory tract (3)
Bordet and Gengou first discovered it in Paris in 1900. They identified “a small ovoid Gram-negative bacterium” in a specimen collected from a 5-month-old child. They actually isolated the bacterium 6 years later from Bordet’s own son. Since then, it has been responsible for multiple outbreaks with the largest peak in recent years in 2012. Furthermore, just this year there has been an outbreak in Nunavut community (4).
Domain: Bacteria
Phylum: Proteobacteria
Class: Betaproteobacteria
Order: Burkholderiales
Family: Alcaligenaceae
Genus: Bordetella
Species: B. pertussis
(https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi)
Bordetella pertussis can’t really be confused for something else. It has very specific requirements and tests negative for many things that other microbes would test positive for. For example, just the fact that it can’t ferment most sugars and carbohydrates would separate it from many other microbes. Additionally, it produces a specific hemolysin toxin that could help discern it from other microbes (9). Furthermore, it doesn’t grow on an ordinary blood agar plate or a MacConkey Agar plate, my microbe has its own selective plate called Bordet Gengou Blood Agar (8).
Bordetella pertussis is a pathogen that causes whooping cough. It does not have any benefits to the host (11).
It is important because it causes a highly contagious infection of the respiratory tract. The microbe is spread through respiratory droplets and the disease it causes results in coughing spasms that can contribute to spread. It can also cause severe harm to infants and can lead to many respiratory complications. Bordetella pertussis also has many self-defense mechanisms that help it persist longer in the respiratory track such as adenylate cyclase toxin which combats the body’s immune response, as well as pertussis toxin (3).
There is no proven effective treatment for reducing the pertussis symptoms, however antibiotics are used to prevent further transmission (3). Some antibiotics that are used are: Amoxicillin, Azithromycin, Clarithromycin, and Erythromycin. Additionally, babies get a vaccine when they are young to prevent infection.
(https://app.gideononline.com/explore/microbes/bacteria/800)
The BSL level for my microbe is 2. Basic laboratory measures such as wearing appropriate clothing and disinfecting work areas after use should be in place. Additionally, special containment practices and devices are generally required to decrease the risk to laboratory personnel.
You need a Bordet-Gengou Agar in order to grow Bordetella pertussis. This type of agar is optimized to isolate Bordetella. It is an enriched casein peptone medium and has a potato infusion as well as glycerol to supply nutrients. Blood is also added to supply additional nutrients and allow for the detection of hemolytic reactions.
Bordetella pertussis needs to be grown in aerobic conditions.
Open vial according to enclosed instructions
Use one tube of #35 broth (5-6 mL)
Use pipette to withdraw 0.5-1 mL and rehydrate entire pellet
Aseptically transfer this back into the broth tube.
Mix well
Incubate the tubes and plate at 37 degrees Celsius for 24-48 hours
(https://www.atcc.org/products/all/8467.aspx#documentation)
Using primers in literature to run in In silico PCR amplification and BLAST to find 16S ribosomal RNA
Primers:
16S-F2: 5’-AACTGCATTTTTAACTACCGG-3’ (12)
Melting temperature: 48.5 Celsius
GC content: 38%
16S-R1: 5'-ATCCTGTTTGCTCCCCACA-3' (12)
Melting temperature: 51.1 Celsius
GC content: 53%
(http://biotools.nubic.northwestern.edu/OligoCalc.html)
In silico PCR Amplification result:
>NC_002929, from 2149665 to 2149824 (160 bp); Bordetella pertussis
AACTGCATTTTTAACTACCGGGCTAGAGTGTGTCAGAGGGAGGTGGAATTCCGCGTGTAGCAGTGAAATGCGTAGATATGCGGAGGAACACCGATGGCGAAGGCAGCCTCCTGGGATAACACTGACGCTCATGCACGAAAGTGTGGGGAGCAAACAGGAT
(http://insilico.ehu.eus/find_gene.php?genome=002929&start=2149665&length=160)
BLAST Result:
>NR_025951.1 Bordetella pertussis strain 18323 16S ribosomal RNA, partial sequence
AACTGAAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGGATGCTTTACACATGCAAGTCGGACGGCAGCACGGGCTTCGGCCTNGTGGCGAGTGGCGAACGGGTGAGTAATGTATCGGAACGTGCCCAGTAGCGGGGGATAACTACGCGAAAGCGTAGCTAATACCGCATACGCCCTACGGGGGAAAGCGGGGGACCTTCGGGCCTCGCACTATTGGAGCGGCCGATATCGGATTAGCTNGTTGGTGGGGTAACGGCCTACCAAGGCGACGATCCGTAGCTGGTTTGAGAGGACGACCAGCCACACTGGGACTGAGACACGGCCCAGNCTCCTACGGGAGGCAGCAGTGGGGAATTTTGGACAATGGGGGCAACCCTGATCCAGCCATCCCGCGTGTGCGATGAAGGCCTTCGGGTTGTAAAGCACTTTTGGCAGGAAAGAAACGGCACGGGCTAATATCCTGTGCAACTGACGGTACCTGCAGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGTGCGCAGGCGGTTCGGAAAGAAAGATGTGAAATCCCAGGGCTTAACCTTGGAACTGCATTTTTAACTACCGGGCTAGAGTGTGTCAGAGGGAGGTGGAATTCCGCGTGTAGCAGTGAAATGCGTAGATATGCGGAGGAACACCGATGGCGAAGGCAGCCTCCTGGGATAACACTGACGCTCATGCACGAAAGTGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGTCAACTAGCTGTTGGGGCCTTCGGGCCTTGGTAGCGCAGCTAACGCGTGAAGTTGACCGCCTGGGGAGTACGGTCGCAAGATTAAAACTCAAAGGAATTGACGGGGACCCGCACAAGCGGTGGATGATGTGGATTAATTCGATGCAACGCGAAAAACCTTACCTACCCTTGACATGTCTGGAATCCCGAAGAGATTTGGGAGTGCTCGCAAGAGAACCGGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCATTAGTTGCTACGAAAGGGCACTCTAATGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTGAAGTCCTCATGGCCCTTATGGGTAGGGCTTCACACGTCATACAATGGTCGGGACAGAGGGTTGNCAACCCGCGAGGGGGAGCCAATCCCAGAAACCCGGTCGTNGTCCGGATCGCAGTCTGCAACTCGACTGCGTGAAGTCGGAATCGCTAGTAATCGCGGATCAGCATGTCGCGGTGAATACGTTCCCGGGTCTTGTACACACCGCNCGTCACACCATGGGAGTGGGTTTTACCAGAAGTAGTTAGCCTAACCGCAAGGGGGGCGATTACCACGGTAGGA
(https://blast.ncbi.nlm.nih.gov/Blast.cgi#alnHdr_219846360)
Mai-Prochnow A, Clauson M, Hong J, Murphy A. 2016. Gram positive and Gram-negative bacteria differ in their sensitivity to cold plasma. Sci Rep 6(38610). 10.1038/srep38610.
Albrecht T, Baron S. 1996. Medical microbiology, 4th ed. University of Texas Medical Branch at Galveston, Dept. of Microbiology & Immunology, Galveston, TX.
Carbonetti NH. 2016. Bordetella pertussis: new concepts in pathogenesis and treatment. Curr Opin Infect Dis. 29(3):287-294 doi:10.1097/QCO.0000000000000264
Guiso N. 2009. Bordetella pertussis and Pertussis Vaccines. Clin Infect Dis 49(10):1565-1569. doi: 10.1086/644733
Sato Y, Izumiya K, Sato H, Cowell J, Manclark C. 1980. Aerosol infection of mice with Bordetella pertussis. Infect Immun 29(1):261-266. 0019-9567/80/07-0261/06$02.00/0.
Bassinet L, Gueirard P, Maitre B, Housset B, Gounon P, Guiso N. 2000. Role of Adhesins and Toxins in Invasion of Human Tracheal Epithelial Cells by Bordetella pertussis. Infect Immun 68(4):1934-1941. 10.1128/iai.68.4.1934-1941.2000.
Cattelan N, Yantorno O, Deora R. 2018. Structural Analysis of Bordetella pertussis Biofilms by Confocal Laser Scanning Microscopy. Bio Protoc 8(15):e2953. 10.21769/BioProtoc.2953.
Rowatt E. 1957. The Growth of Bordetella pertussis: a Review. J. Gen. Microbiol. 17:297-326.
Albrecht T, Baron S. 1996. Medical microbiology, 4th ed. University of Texas Medical Branch at Galveston, Dept. of Microbiology & Immunology, Galveston, TX.
Conover, M. S., Mishra, M., & Deora, R. 2011. Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PloS one 6(2), e16861. 10.1371/journal.pone.0016861
Elizabeth A. Trainor, Tracy L. Nicholson, Tod J. Merkel. 2015. Bordetella pertussis transmission. Pathog Dis 73(8) doi: 10.1093/femspd/ftv068
Jung S, Moon Y, Sung H, Kang Y, Yu J. 2008. Discriminative PCR of Bordetella pertussis from closely related Bordetella species using 16S rDNA Gene. Infect Chemother. 40(1): 24-31. 10.3947/ic.2008.40.124
My name is Sharon Johnson and here are some fun facts about myself:
I own three chickens in Miami
I want to be a Bioinformatician
I'm Indian, but I was born in Bahrain which is a small island, country, kingdom
I love doing research and would do it 100% instead of classes
I only have one good picture of myself and it's the one on the left